These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 17908770)

  • 1. Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development.
    Gordon LB; McCarten KM; Giobbie-Hurder A; Machan JT; Campbell SE; Berns SD; Kieran MW
    Pediatrics; 2007 Oct; 120(4):824-33. PubMed ID: 17908770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hutchinson-Gilford progeria syndrome.
    Wisuthsarewong W; Viravan S
    J Med Assoc Thai; 1999 Jan; 82(1):96-102. PubMed ID: 10087745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal neonatal Hutchinson-Gilford progeria syndrome.
    Rodríguez JI; Pérez-Alonso P; Funes R; Pérez-Rodríguez J
    Am J Med Genet; 1999 Jan; 82(3):242-8. PubMed ID: 10215548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Harten IA; Patti ME; Lichtenstein AH
    J Pediatr; 2005 Mar; 146(3):336-41. PubMed ID: 15756215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
    Bridger JM; Kill IR
    Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
    Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
    Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
    Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI
    Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on a case of Hutchinson-Gilford progeria, with special reference to orthopedic problems.
    Fernandez-Palazzi F; McLaren AT; Slowie DF
    Eur J Pediatr Surg; 1992 Dec; 2(6):378-82. PubMed ID: 1477072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hutchinson-Gilford Progeria Syndrome: a case report.
    Russo-Menna I; Arancibias C
    Minerva Anestesiol; 2010 Feb; 76(2):151-4. PubMed ID: 20150858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal maturation and long-bone growth patterns of patients with progeria: a retrospective study.
    Tsai A; Johnston PR; Gordon LB; Walters M; Kleinman M; Laor T
    Lancet Child Adolesc Health; 2020 Apr; 4(4):281-289. PubMed ID: 32119840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hutchinson-Gilford progeria syndrome with severe skin calcinosis.
    Nakamura S; Makita Y; Takagi A; Hashimoto Y; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2007 Sep; 32(5):525-8. PubMed ID: 17459069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length in Hutchinson-Gilford progeria syndrome.
    Decker ML; Chavez E; Vulto I; Lansdorp PM
    Mech Ageing Dev; 2009 Jun; 130(6):377-83. PubMed ID: 19428457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases of Hutchinson-Gilford progeria syndrome].
    Doubaj Y; Lamzouri A; Elalaoui SC; Laarabi FZ; Sefiani A
    Arch Pediatr; 2011 Feb; 18(2):156-9. PubMed ID: 21251803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hutchinson-Gilford progeria. A rare case of neonatal occurrence].
    Zucchini A; Bonfiglioli G; Masignà Ricciardi MG
    Pediatr Med Chir; 1986; 8(4):583-5. PubMed ID: 3575136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Kleinman ME; Massaro J; D'Agostino RB; Shappell H; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland RH; Nazarian A; Snyder BD; Ullrich NJ; Silvera VM; Liang MG; Quinn N; Miller DT; Huh SY; Dowton AA; Littlefield K; Greer MM; Kieran MW
    Circulation; 2016 Jul; 134(2):114-25. PubMed ID: 27400896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecan expression is substantially and abnormally upregulated in Hutchinson-Gilford Progeria Syndrome dermal fibroblasts.
    Lemire JM; Patis C; Gordon LB; Sandy JD; Toole BP; Weiss AS
    Mech Ageing Dev; 2006 Aug; 127(8):660-9. PubMed ID: 16650460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome.
    Gerhard-Herman M; Smoot LB; Wake N; Kieran MW; Kleinman ME; Miller DT; Schwartzman A; Giobbie-Hurder A; Neuberg D; Gordon LB
    Hypertension; 2012 Jan; 59(1):92-7. PubMed ID: 22083160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progeria.
    Badame AJ
    Arch Dermatol; 1989 Apr; 125(4):540-4. PubMed ID: 2649013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KBG syndrome.
    Brancati F; Sarkozy A; Dallapiccola B
    Orphanet J Rare Dis; 2006 Dec; 1():50. PubMed ID: 17163996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip pathology in Hutchinson-Gilford progeria syndrome: a report of two children.
    Akhbari P; Jha S; James KD; Hinves BL; Buchanan JA
    J Pediatr Orthop B; 2012 Nov; 21(6):563-6. PubMed ID: 22433957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.